スイスの股関節置換インプラント市場 – 業界動向と2030年までの予測

スイスの人工股関節置換インプラント市場の分析と規模

股関節インプラントは、骨の一部が欠損している場合、またはそれ以上の損傷を防ぐためにその骨に特定の支持関節が作られている場合に使用される医療機器です。この人工インプラントは、最大限の強度を得るためにステンレス鋼とチタンなどの合金で作られており、関節の構造と機能を維持するために体の股関節の軟骨として機能するプラスチックでラベル付けされています。最小限の外科手術を必要とする手術の場合、股関節損傷の治療でよく見られるタイプの人工インプラントは、股関節狭窄などの他の同様の状態で使用されます。近年、骨格に関連するさまざまな忍び寄る病気の発症により、股関節損傷の数が急増しています。高齢者のその他の局所的な転倒損傷の頻度も、市場の成長の原動力であることが証明されています。さらに、ロボット手術装置、股関節インプラントとインプラント可能な医療機器の急速な採用、および股関節関連の問題を治療するための他の多くの最新技術などの技術の進歩と革新が、予測期間中に市場を活性化させました。

股関節の損傷や股関節炎などの疾患の増加、整形外科疾患にかかりやすい高齢者人口の急増は、市場の成長を牽引する要因の一部です。しかし、股関節置換治療における先進技術の使用に伴う高コストは、市場の成長を阻害する主な要因の 1 つです。その結果、長期的には市場の成長が妨げられる可能性があります。

新興経済国は、市場の成長に有利な成長機会をもたらすと予想されています。一方で、股関節インプラントの製品不良や製品リコールは、市場の成長に悪影響を及ぼす可能性があります。

Data Bridge Market Research の分析によると、スイスの人工股関節置換インプラント市場は、予測期間中に 10.5% の CAGR で成長し、2030 年までに 9,892 万米ドルに達する見込みです。製品タイプは、スイスの人工股関節置換インプラント市場で最大のセグメントを占めています。 

Market Definition

Hip replacement is a surgical procedure in which the hip joint is replaced by a prosthetic implant, that is, a hip prosthesis. Hip replacement surgery can be performed as a total replacement or a semi-replacement.

Hip implants are medical devices intended to restore mobility and relieve pain usually associated with arthritis and other hip diseases or injuries. Every hip implant has benefits and risks. Every hip implant system has unique device design features such as size, shape, material, and dimensions. In addition, the same hip implant system may have different outcomes in different patients. There are several factors that may influence the outcome and longevity of a hip implant including the device design features, surgeon experience and implantation technique, and individual patient characteristics such as age, sex, weight, activity level, and overall health.

Swiss Hip Replacement Implant Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

• A rise in the prevalence of hip arthritis

One of the most common crippling joint conditions, arthritis, causes harm to the articular cartilage, subchondral bone, and synovium, among other joint components. With considerable effects on those affected, healthcare systems, and large socioeconomic consequences, arthritis is a major public health concern. Even though arthritis can affect any joint, the hip accounts for a significant amount of the disease burden. Hip arthritis can eventually result in joint failure and necessitate surgical replacement. Hip arthritis is the deterioration of the cartilage of the hip joint. The hip is a ball-and-socket joint with the ball at the top of the thighbone (the femoral head). The ball is separated from the socket (the acetabulum) by cartilage.

Thus, the rise in the prevalence of hip arthritis in Switzerland is expected to drive market growth.

• Government and private initiatives for healthcare and insurance investments

Switzerland's universal health care system is highly decentralized, with the cantons, or states, playing a key role in its operation. The system is funded through enrollee premiums, taxes (mostly cantonal), social insurance contributions, and out-of-pocket payments. Residents are required to purchase insurance from private non-profit insurers. Adults also pay yearly deductibles and coinsurance (with an annual cap) for all services. Coverage includes most physician visits, hospital care, pharmaceuticals, devices, home care, medical services in long-term care, and physiotherapy. Supplemental private insurance can be purchased for services not covered by mandatory health insurance to secure a greater choice of physicians and to obtain better hospital accommodations.

Since health care is largely decentralized, the key entities for health system governance exist mainly at the cantonal level. Each canton has its elected minister of public health; a coordinating political body, the Swiss Conference of Cantonal Health Ministers, plays an important role.

Thus, the government and private initiatives for healthcare and insurance investments are expected to act as a driver for market growth.

OPPORTUNITY

• Rising product innovations and development owing to technological advancements

Technological developments in hip replacement implants result in additional functionality, higher success rate, and newer materials, depending on their use in different hip replacement procedures. The commercializing of advanced technology-based hip replacement implants used for implants and surgical procedures has increased its demand among consumers, due to which growing technological advancement is propelling the market demand and growth.

Thus, technological advancements and the development of precise orthopedic implants are expected to act as an opportunity for market growth.

RESTRAINTS/CHALLENGES

• Product recalls and product failures

Several joint manufacturers have recalled metal-on-metal hip implants during the past decade. The companies promised their metal-on-metal designs would increase mobility. But certain hip replacements may be more prone to failure and recall.

For instance,

• A 2022 study reported that, following a hip replacement, 46.7% of participants experienced a clinically significant improvement, while 15.5% experienced worsened outcomes.

Thus, product recalls and product failures are expected to act as a restraint for market growth.

• Stringent regulatory framework

Achieving the requisite approval for the legal selling of hip implants and replacement products in such jurisdictions can entail significant financial expenditure, which could take months or years to complete. Delays may significantly jeopardize the chances of success in a highly competitive market if these limitations are not known or considered.

As per the Federal Office of Public Health (FOPH), Switzerland has adapted its medical device regulations to the EU (Europe) rules in the interests of patient safety and EU market access for the Swiss medical devices industry. The changes will also have implications for human research legislation.

Hence, strict regulations for the approval of new devices are expected to challenge market growth.

Post-COVID-19 Impact on the Swiss Hip Replacement Implants Market

COVID-19 has significantly and negatively impacted the market. During this phase, there was a huge drop in the number of non-elective and non-essential surgical procedures and hip and knee arthroplasty surgeries did not make it to the list of essential surgeries. Significant financial losses in this pandemic phase resulted in derailing market growth.

Recent Developments

• In April 2021, Corin Group announced the launch of OPSInsight preoperative planning software for Total Hip Arthroplasty (THA). This cloud-based platform represents the next generation of Corin's pioneering Optimized Positioning System (OPS) technology, which helps to assess the patient's unique joint biomechanics.
• In August 2021, DJO Switzerland announced the launch of EMPOWR Dual Mobility, which is a product of the hip portfolio that provides surgeons with a solution to treat a large patient group needing better joint stability.

Swiss Hip Replacement Implants Market Scope  

The swiss hip replacement implants market is segmented into four notable segments based on product type, material, end user, and distribution channel. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.  

BY PRODUCT TYPE

• FEMORAL RECONSTRUCTION
• ACETABULAR RECONSTRUCTION
• HIP RESURFACING
• REVISION HIP IMPLANTS
• BEARING AND POROUS METAL TECHNOLOGIES
• TOTAL REPLACEMENT IMPLANTS

Based on product type, the market is segmented into femoral reconstruction, acetabular reconstruction, hip resurfacing, revision hip implants, bearing and porous metal technologies, and total replacement implants. 

BY MATERIAL

• CERAMIC-ON-CROSS-LINKED POLYETHYLENE
• CERAMIC-ON-POLYETHYLENE
• CERAMIC-ON-CERAMIC
• METAL-ON-CROSS-LINKED POLYETHYLENE
• OTHERS

Based on material, the market has been segmented into ceramic-on-cross-linked polyethylene, ceramic-on-polyethylene, ceramic-on-ceramic, metal-on-cross-linked polyethylene, and others.  

BY END USER

• ORTHOPEDIC CLINICS
• HOSPITALS & SURGERY CENTERS
• OTHERS

Based on end user, the market has been segmented into orthopedic clinics, hospitals & surgery centers, and others.

BY DISTRIBUTION CHANNEL

• DIRECT SALES
• THIRD-PARTY DISTRIBUTORS
• RETAIL SALES

Based on distribution channel, the market has been segmented into direct sales, third-party distributors, and retail sales.

Competitive Landscape and Swiss Hip Replacement Implants Market Share Analysis

スイスの人工股関節置換インプラント市場の競争状況は、競合他社の詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、ヨーロッパでのプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性が含まれます。提供されている上記のデータ ポイントは、市場に対する会社の焦点にのみ関連しています。

スイスの人工股関節置換インプラント市場で事業を展開している主要企業としては、Atesos、B. Braun Melsungen AG、Conformis、Corin Group、DePuy Synthes Companies、DJO, LLC、Exactech, Inc.、KYOCERA Medical Technologies, Inc.、Mathys Ltd Bettlach、Medacta International、MicroPort Scientific Corporation、Smith & Nephew、Stryker、Symbios Orthopedie SA、Waldemar Link GmbH & Co. KG、Zimmer Biomet などがあります。

SKU-69799